An In Vivo Microdialysis Study of Striatal 6-[18F]Fluoro-L-m-Tyrosine Metabolism |
| |
Authors: | Jordan Shaun Bankiewicz Krzysztof S Eberling Jamie L VanBrocklin Henry F O'Neil James P Jagust William J |
| |
Institution: | (1) Center for Functional Imaging, University of California, Lawrence Berkeley Laboratory, 55-121, Berkeley, CA, 94720;(2) Somatix Therapy Corporation, Alameda, CA, 94501;(3) Department of Neurology, University of California Davis, Davis, CA, 95616;(4) Department of Pharmacokinetics & Drug Metabolism, Parke-Davis Pharmaceutical Research Division, Warner Lambert Company, Ann Arbor, Michigan, MI, 48105 |
| |
Abstract: | In vivo brain microdialysis was used to monitor 6-18F]fluoro-L-m-tyrosine (FMT) uptake and metabolism in the striatum of conscious freely moving rats for 3 hours after FMT injection (25 mg/kg, iv). Microdialysate collected 20 to 120 min post-dose, contained FMT at a concentration (0.2 to 0.3 nM) approximately ten-fold below that of its metabolite 18F]fluoro-3-hydroxyphenylacetic acid (FPAC; 3.2 to 3.3 nM). D-amphetamine (2.5 mg/kg, i.p.) injected 120 min after significantly increased microdialysate FPAC (3.27 ± 0.31 nM to 4.51 ± 0.45 nM) in control but not reserpinized rats. Taken together these data demonstrate FMT is heavily metabolized following its entry into the striatum yielding FPAC which appears to be stored, at least in part, in reserpine sensitive cytoplasmic vesicles. Presynaptic retention of FPAC may contribute to the preferential accumulation of FMT positron emission tomography (PET) signaling in dopaminergic brain areas. |
| |
Keywords: | Amphetamine 6-[18F]fluoro-L-m-tyrosine metabolism microdialysis PET striatum |
本文献已被 SpringerLink 等数据库收录! |
|